✨ Education and Health Notices
30 AUGUST
NEW ZEALAND GAZETTE
2809
Education
Private Schools Conditional Integration Act 1975
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Sacred Heart Girls College, New Plymouth.
The said supplementary integration agreement was executed on 21 August 2001.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the district office of the Ministry of Education, 116 Victoria Avenue, Wanganui.
Dated at Wellington this 21st day of August 2001.
KATHY PHILLIPS, Senior Manager, National Operations.
go5954
Education Act 1989
Amendment to Extension of Term of Office of Commissioner at Kimi Ora Community School
Acting under delegated authority, pursuant to section 109 (7B) of the Education Act 1989, I hereby amend the notice published in the New Zealand Gazette, 15 March 2001, page 619, by omitting the words
“30 November 2001”
and substituting the words
“19 November 2001”.
Dated at Wellington this 22nd day of August 2001.
KATHY PHILLIPS, Senior Manager, National Operations.
go5970
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Cellugel Viscoelastic Solution
Active Ingredient(s):
Hypromellose 23mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Alcon Couvreur SA, Puurs, Belgium
Product:
Dilaudid
Active Ingredient(s):
Hydromorphone hydrochloride 2mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Knoll Australia Pty Limited
Manufacturer(s):
Abbott Laboratories Inc, McPherson, Kansas, United States of America
Product:
Dilaudid
Active Ingredient(s):
Hydromorphone hydrochloride 1mg/mL
Dosage Form:
Oral solution
New Zealand Sponsor:
Knoll Australia Pty Limited
Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America
Product:
Dilaudid
Active Ingredient(s):
Hydromorphone hydrochloride 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Knoll Australia Pty Limited
Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America
Product:
Dilaudid
Active Ingredient(s):
Hydromorphone hydrochloride 4mg
Dosage Form:
Tablet
New Zealand Sponsor:
Knoll Australia Pty Limited
Manufacturer(s):
Knoll Pharmaceutical Company, Whippany, New Jersey, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 109
Gazette.govt.nz —
NZ Gazette 2001, No 109
✨ LLM interpretation of page content
🎓 Supplementary Integration Agreement for Sacred Heart Girls College
🎓 Education, Culture & Science21 August 2001
Private Schools Conditional Integration Act 1975, Sacred Heart Girls College, New Plymouth, Supplementary Integration Agreement
- KATHY PHILLIPS, Senior Manager, National Operations
🎓 Amendment to Extension of Term of Office of Commissioner at Kimi Ora Community School
🎓 Education, Culture & Science22 August 2001
Education Act 1989, Kimi Ora Community School, Term of Office, Commissioner
- KATHY PHILLIPS, Senior Manager, National Operations
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines Act 1981, Cellugel Viscoelastic Solution, Dilaudid, Hydromorphone hydrochloride, Pacific Pharmaceuticals Limited, Knoll Australia Pty Limited